Journal Title：Medical Hypotheses

Medical Hypotheses is a forum for ideas in medicine and related biomedical sciences. It will publish interesting and important theoretical papers that foster the diversity and debate upon which the scientific process thrives. The Aims and Scope of Medical Hypotheses are no different now from what was proposed by the founder of the journal, the late Dr David Horrobin. In his introduction to the first issue of the Journal, he asks 'what sorts of papers will be published in Medical Hypotheses? and goes on to answer 'Medical Hypotheses will publish papers which describe theories, ideas which have a great deal of observational support and some hypotheses where experimental support is yet fragmentary'. (Horrobin DF, 1975 Ideas in Biomedical Science: Reasons for the foundation of Medical Hypotheses. Medical Hypotheses Volume 1, Issue 1, January-February 1975, Pages 1-2.). Medical Hypotheses was therefore launched, and still exists today, to give novel, radical new ideas and speculations in medicine open-minded consideration, opening the field to radical hypotheses which would be rejected by most conventional journals. Papers in Medical Hypotheses take a standard scientific form in terms of style, structure and referencing. The journal therefore constitutes a bridge between cutting-edge theory and the mainstream of medical and scientific communication, which ideas must eventually enter if they are to be critiqued and tested against observations.

《醫學假說》是醫學和相關生物醫學科學思想的論壇。它將發表有趣而重要的理論論文，以促進科學過程蓬勃發展的多樣性和辯論。《醫學假說》的目標和范圍與該雜志的創始人已故的 David Horrobin 博士提出的目標和范圍沒有什么不同。在該雜志第一期的介紹中，他問道：“《醫學假說》將發表什么樣的論文？”并繼續回答“《醫學假說》將發表描述理論、有大量觀察支持的思想和一些實驗支持尚不完整的假設的論文”。（Horrobin DF，1975 年《生物醫學科學思想：醫學假說創立的原因》。《醫學假說》第 1 卷，第 1 期，1975 年 1 月至 2 月，第 1-2 頁。）因此，《醫學假說》雜志應運而生，至今仍然存在，旨在以開放的心態考慮醫學領域新穎、激進的新思想和推測，為大多數傳統期刊拒絕的激進假說打開大門。《醫學假說》雜志上的論文在風格、結構和參考文獻方面采用標準的科學形式。因此，該雜志構成了前沿理論與醫學和科學交流主流之間的橋梁，如果要對思想進行批評和根據觀察進行檢驗，這些思想最終必須進入這一領域。

Medical Hypotheses創刊于1975年，由Churchill Livingstone出版商出版，收稿方向涵蓋醫學 - 醫學：研究與實驗全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 約2.8個月 ，影響因子指數2.1，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。